FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Brooks Jackson

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Geographic Areas

Uganda

Physiology

Concepts & Ideas

Viral Load

Procedures

Co-author Network

Publications

TOP 3
J Brooks Jackson; Laurie Sneed; Xuguang Tao; Frances Humphrey-Carothers; Edward Bernacki
Cost of annual tuberculosis screening of healthcare workers with negative tuberculin skin test results.
Michael G Hudgens; J Brooks Jackson; Denise J Jamieson; Athena P Kourtis; Newton Kumwenda; Hana Lee; Lynne M Mofenson; Philippa Musoke; Saad Omer; ANDREA RUFF; Taha E Taha; Allan Taylor; Michael C Thigpen; Abubaker Bedri; Robert Bollinger; Charles Chasela; Nikhil Gupte; Charles van der Horst
Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission.
Timothy K Amukele; Mary Hanes; Kurt Michael; Robert E Miller; J Brooks Jackson
External quality assurance performance of clinical research laboratories in sub-saharan Africa.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Brooks Jackson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: J Brooks Jackson; Laurie Sneed; Xuguang Tao; Frances Humphrey-Carothers; Edward Bernacki
Cost of annual tuberculosis screening of healthcare workers with negative tuberculin skin test results.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2013;34(6):642-3.
2013: Michael G Hudgens; J Brooks Jackson; Denise J Jamieson; Athena P Kourtis; Newton Kumwenda; Hana Lee; Lynne M Mofenson; Philippa Musoke; Saad Omer; ANDREA RUFF; Taha E Taha; Allan Taylor; Michael C Thigpen; Abubaker Bedri; Robert Bollinger; Charles Chasela; Nikhil Gupte; Charles van der Horst
Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(1):131-9.
2012: Timothy K Amukele; Mary Hanes; Kurt Michael; Robert E Miller; J Brooks Jackson
External quality assurance performance of clinical research laboratories in sub-saharan Africa.
American journal of clinical pathology 2012;138(5):720-3.
2012: Peibin Zeng; Simone Glynn; Xiaoming Guo; Miao He; Yi Huang; J Brooks Jackson; Julin Li; Yu Liu; Paul M Ness; Jane Schulmann; Hua Shan; Jingxing Wang; Guoxin Wen; Tonghan Yang; Yuzhe Yuan; Zhongqiao Yun
The human immunodeficiency virus-1 genotype diversity and drug resistance mutations profile of volunteer blood donors from Chinese blood centers.
Transfusion 2012;52(5):1041-9.
2012: Gregory M Lucas; David Metzger; Paul Richardson; Yiming Shao; Apinun Aramrattana; Geetha Beauchamp; David Celentano; Liping Fu; J Brooks Jackson; Wei Liu
Short-term safety of buprenorphine/naloxone in HIV-seronegative opioid-dependent Chinese and Thai drug injectors enrolled in HIV Prevention Trials Network 058.
The International journal on drug policy 2012;23(2):162-5.
2012: K Eipl; L Blagg; K Bwogi; Mahnaz Motevalli-Oliner; Clemensia Nakabiito; A Roots; J Brooks Jackson
Seroprevalence of unexpected red blood cell antibodies among pregnant women in Uganda.
Immunohematology / American Red Cross 2012;28(4):115-7.
2011: Carolyne Onyango-Makumbi; Britta Wahren; Hans Wigzell; Sheryl Zwerski; Gretchen Antelman; Lars Falksveden; Mary Glenn Fowler; Laura A Guay; Francis Mmiro; Lawrence H Moulton; Michael Mubiru; Philippa Musoke; Clemensia Nakabiito; Saad Omer; J Brooks Jackson
Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB/NVP STUDY).
Journal of acquired immune deficiency syndromes (1999) 2011;58(4):399-407.
2011: Jeremy Sugarman; L Wei; S Rose; Y Shao; Apinun Aramrattana; R Baoling; David Celentano; A Corneli; D Donnell; B Dye; J Brooks Jackson; F Liping; T Y Liu; D Metzger
Are there adverse consequences of quizzing during informed consent for HIV research?
Journal of medical ethics 2011;37(11):693-7.
2011: Maria M James; Lei Wang; Philippa Musoke; Deborah Donnell; Joshua Fogel; William I Towler; Leila Khaki; Clemensia Nakabiito; J Brooks Jackson; Susan H Eshleman
Association of HIV diversity and survival in HIV-infected Ugandan infants.
PloS one 2011;6(4):e18642.
2010: Jessica D Church; Wei Huang; Anthony Mwatha; Philippa Musoke; J Brooks Jackson; Danstan Bagenda; Saad Omer; Deborah Donnell; Clemensia Nakabiito; Chineta Eure; Laura A Guay; Allan Taylor; Paul M Bakaki; Flavia Matovu; Michelle McConnell; Mary Glenn Fowler; Susan H Eshleman
Analysis of HIV tropism in Ugandan infants.
Current HIV research 2010;8(7):498-503.
2010: Irene R Lubega; Mary Glenn Fowler; Philippa M Musoke; Ali Elbireer; Danstan Bagenda; George Kafulafula; Jeanne Ko; Linda Mipando; Mike Mubiru; Newton Kumwenda; Taha E Taha; J Brooks Jackson; Laura A Guay
Considerations in using US-based laboratory toxicity tables to evaluate laboratory toxicities among healthy malawian and Ugandan infants.
Journal of acquired immune deficiency syndromes (1999) 2010;55(1):58-64.
2010: William I Towler; Maria M James; Stuart C Ray; Lei Wang; Deborah Donnell; Anthony Mwatha; Laura A Guay; Clemensia Nakabiito; Philippa Musoke; J Brooks Jackson; Susan H Eshleman
Analysis of HIV diversity using a high-resolution melting assay.
AIDS research and human retroviruses 2010;26(8):913-8.
2010: Janis M Taube; Betty Kamira; Mahnaz Motevalli-Oliner; Clemensia Nakabiito; Robert Lukande; Deidra P Kelly; Yener S Erozan; Patti Gravitt; Megan E Buresh; Francis Mmiro; Danstan Bagenda; Laura A Guay; J Brooks Jackson
Human papillomavirus prevalence and cytopathology correlation in young Ugandan women using a low-cost liquid-based Pap preparation.
Diagnostic cytopathology 2010;38(8):555-63.
2010: Oliver Laeyendecker; Jessica D Church; Amy E Oliver; Anthony Mwatha; S Michele Owen; Deborah Donnell; Ron Brookmeyer; Philippa Musoke; J Brooks Jackson; Laura A Guay; Clemesia Nakabiito; Thomas C Quinn; Susan H Eshleman
Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay.
PloS one 2010;5(10):e13259.
2009: Caroline E Boeke; Megan E Pauly; Holly Hatch Stock; Stephanie Pavlis; J Brooks Jackson
The association of gender, age, body mass index, and vital signs in healthy plateletapheresis donors.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2009;41(3):175-8.
2009: Carlum Shiu; Coleen K Cunningham; Thomas Greenough; Petronella Muresan; Victor Sanchez-Merino; Vincent Carey; J Brooks Jackson; Carrie Ziemniak; Lawrence Fox; Marvin Belzer; Stuart C Ray; Katherine Luzuriaga; Deborah Persaud
Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretroviral therapy.
Journal of virology 2009;83(19):9731-42.
2009: Wei Huang; Susan H Eshleman; Jonathan Toma; Eric Stawiski; Jeannette M Whitcomb; J Brooks Jackson; Laura A Guay; Philippa Musoke; Neil Parkin; Christos J Petropoulos
Vertical transmission of X4-tropic and dual-tropic HIV-1 in five Ugandan mother-infant pairs.
AIDS (London, England) 2009;23(14):1903-8.
2009: Francis Mmiro; Jim Aizire; Anthony K Mwatha; Susan H Eshleman; Deborah Donnell; Mary Glenn Fowler; Clemensia Nakabiito; Philippa M Musoke; J Brooks Jackson; Laura A Guay
Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda.
Journal of acquired immune deficiency syndromes (1999) 2009;52(1):32-9.
2009: J Brooks Jackson; James D Dick; Tsigereda Tekle; Antoine Simmons; Karen C Carroll
Lack of antimicrobial activity by the antiretroviral drug nevirapine against common bacterial pathogens.
Antimicrobial agents and chemotherapy 2009;53(8):3606-7.
2009: Jessica D Church; Wei Huang; Neil Parkin; Natalia Marlowe; Laura A Guay; Saad Omer; Philippa Musoke; J Brooks Jackson; Susan H Eshleman
Comparison of laboratory methods for analysis of non-nucleoside reverse transcriptase inhibitor resistance in Ugandan infants.
AIDS research and human retroviruses 2009;25(7):657-63.
2009: Jessica D Church; Anthony Mwatha; Danstan Bagenda; Saad Omer; Deborah Donnell; Philippa Musoke; Clemensia Nakabiito; Chineta Eure; Paul M Bakaki; Flavia Matovu; Michael C Thigpen; Laura A Guay; Michelle McConnell; Mary Glenn Fowler; J Brooks Jackson; Susan H Eshleman
In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine.
AIDS research and human retroviruses 2009;25(7):673-7.
2009: Sarah E Hudelson; Natalia Marlowe; Wei Huang; Robert Bruce; Jessica D Church; Marla J Husnik; Deborah Donnell; Thomas Coates; J Brooks Jackson; Margaret A Chesney; Beryl A Koblin; Susan H Eshleman
Analysis of HIV type 1 gp41 and enfuvirtide susceptibility among men in the United States who were HIV infected prior to availability of HIV entry inhibitors.
AIDS research and human retroviruses 2009;25(7):701-5.
2009: April DeLaurier; Alan Boyde; J Brooks Jackson; Michael A Horton; Joanna S Price
Identifying early osteoclastic resorptive lesions in feline teeth: a model for understanding the origin of multiple idiopathic root resorption.
Journal of periodontal research 2009;44(2):248-57.
2008: Kumud K Singh; Michael D Hughes; Jie Chen; Kelesitse Phiri; Christine Rousseau; Louise Kuhn; Anna Coutsoudis; J Brooks Jackson; Laura A Guay; Philippa Musoke; Francis Mmiro; Richard D Semba; Stephen A Spector
Associations of chemokine receptor polymorphisms With HIV-1 mother-to-child transmission in sub-Saharan Africa: possible modulation of genetic effects by antiretrovirals.
Journal of acquired immune deficiency syndromes (1999) 2008;49(3):259-65.
2008: Philippa M Musoke; Alicia M Young; Maxensia A Owor; Irene R Lubega; Elizabeth R Brown; Francis Mmiro; Lynne M Mofenson; J Brooks Jackson; Mary Glenn Fowler; Laura A Guay
Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan children.
Journal of acquired immune deficiency syndromes (1999) 2008;49(2):171-8.
2008: Jessica D Church; Saad Omer; Laura A Guay; Wei Huang; Jessica Lidstrom; Philippa Musoke; Francis Mmiro; J Brooks Jackson; Susan H Eshleman
Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission.
The Journal of infectious diseases 2008;198(7):1075-82.
2008: William Ian Towler; Jessica D Church; James R Eshleman; Mary Glenn Fowler; Laura A Guay; J Brooks Jackson; Susan H Eshleman
Analysis of nevirapine resistance mutations in cloned HIV type 1 variants from HIV-infected Ugandan infants using a single-step amplification-sequencing method (AmpliSeq).
AIDS research and human retroviruses 2008;24(9):1209-13.
2008: Abubaker Bedri; Berhanu Gudetta; Abdulhamid Isehak; Solomon Kumbi; Sileshi Lulseged; Yohannes Menigstu; Arvind V Bhore; Ramesh Bhosale; Venkat Varadhrajan; Nikhil Gupte; Jayagowri Sastry; Nishi Suryavanshi; Srikanth Tripathy; Francis Mmiro; Michael Mubiru; Carolyne Onyango; Adrian Taylor; Philippa Musoke; Clemensia Nakabiito; AIDA ABASHAWL; RAHEL ADAMU; Gretchen Antelman; Robert Bollinger; PATRICIA BRIGHT; MOHAMMAD CHAUDHARY; Jacqueline Coberly; Laura A Guay; Mary Glenn Fowler; Amita Gupta; ELHAM HASSEN; J Brooks Jackson; Lawrence H Moulton; Uma Nayak; Saad Omer; MARIA LIDIA PROPPER; MALATHI RAM; Vivian Rexroad; ANDREA RUFF; Anita V Shankar; Sheryl Zwerski
Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials.
Lancet 2008;372(9635):300-13.
2008: Jessica D Church; Wei Huang; Anthony Mwatha; Jonathan Toma; Eric Stawiski; Deborah Donnell; Laura A Guay; Francis Mmiro; Philippa Musoke; J Brooks Jackson; Neil Parkin; Susan H Eshleman
HIV-1 tropism and survival in vertically infected Ugandan infants.
The Journal of infectious diseases 2008;197(10):1382-8.
2008: Caroline E Boeke; J Brooks Jackson
Estimate of infant HIV-free survival at 6 to 8 weeks of age due to maternal antiretroviral prophylaxis in Sub-Saharan Africa, 2004-2005.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 2008;7(3):133-40.
2008: Estelle Piwowar-Manning; Lebah Lugalia; Bosco Kafufu; J Brooks Jackson
Comparison of results obtained with Amplicor HIV-1 DNA PCR test version 1.5 using 100 versus 500 microliters of whole blood.
Journal of clinical microbiology 2008;46(3):1104-5.
2008: Caroline E Boeke; Megan E Pauly; Holly Hatch-Stock; J Brooks Jackson
CMV antibody prevalence and seroincidence in plateletpheresis donors.
Journal of clinical apheresis 2008;23(2):63-5.
2007: Victoria B Chou; Saad Omer; Hamidah Hussain; Christine Mugasha; Maria Musisi; Francis Mmiro; Philippa Musoke; J Brooks Jackson; Laura A Guay
The costs associated with adverse event procedures for an international HIV clinical trial determined by activity-based costing.
Journal of acquired immune deficiency syndromes (1999) 2007;46(4):426-32.
2007: Tamara Flys; Anthony Mwatha; Laura A Guay; Clemensia Nakabiito; Deborah Donnell; Philippa Musoke; Francis Mmiro; J Brooks Jackson; Susan H Eshleman
Detection of K103N in Ugandan women after repeated exposure to single dose nevirapine.
AIDS (London, England) 2007;21(15):2077-82.
2007: Wei Huang; Susan H Eshleman; Jonathan Toma; Signe Fransen; Eric Stawiski; Ellen Paxinos; Jeannette M Whitcomb; Alicia M Young; Deborah Donnell; Francis Mmiro; Philippa Musoke; Laura A Guay; J Brooks Jackson; Neil Parkin; Christos J Petropoulos
Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations.
Journal of virology 2007;81(15):7885-93.
2007: Janis M Taube; Andrew D Nichols; Lynette S Bornman; Daniel M Bornman; J Brooks Jackson
Langerhans cell density and high-grade vulvar intraepithelial neoplasia in women with human immunodeficiency virus infection.
Journal of cutaneous pathology 2007;34(7):565-70.
2007: Taha E Taha; Donald R Hoover; Newton Kumwenda; Susan A Fiscus; George Kafulafula; Chiwawa Nkhoma; Shu Chen; Estelle Piwowar; Robin L Broadhead; J Brooks Jackson; Paolo Miotti
Late postnatal transmission of HIV-1 and associated factors.
The Journal of infectious diseases 2007;196(1):10-4.
2007: Yuanzhi Zhang; Hua Shan; Jennifer Trizzino; Yuhua Ruan; Geetha Beauchamp; Benoît Mâsse; Jun Ma; Baoling Rui; Jun Wang; Minsheng Liu; Yunxia Wang; Yixin He; Katharine Poundstone; Yan Jiang; J Brooks Jackson; Yiming Shao
HIV incidence, retention rate, and baseline predictors of HIV incidence and retention in a prospective cohort study of injection drug users in Xinjiang, China.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2007;11(4):318-23.
2007: Jessica D Church; Sarah E Hudelson; Laura A Guay; Shu Chen; Donald R Hoover; Neil Parkin; Susan A Fiscus; Francis Mmiro; Philippa Musoke; Newton Kumwenda; J Brooks Jackson; Taha E Taha; Susan H Eshleman
HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D.
AIDS research and human retroviruses 2007;23(6):764-8.
2007: Susan H Eshleman; Marla J Husnik; Sarah E Hudelson; Deborah Donnell; Yijian Huang; Wei Huang; Stephen Hart; J Brooks Jackson; Thomas Coates; Margaret A Chesney; Beryl A Koblin
Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection.
AIDS (London, England) 2007;21(9):1165-74.
2007: Tamara Flys; Deborah Donnell; Anthony Mwatha; Clemensia Nakabiito; Philippa Musoke; Francis Mmiro; J Brooks Jackson; Laura A Guay; Susan H Eshleman
Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission.
The Journal of infectious diseases 2007;195(5):711-5.
2006: Liu Wei; Jie Chen; Michelle Rodolph; Geetha Beauchamp; Benoît Mâsse; Rongjian Li; Shaoping Wang; Yuhua Ruan; Shenghan Lai; Li Zhang; Feng Zhou; Scott M Rose; Tom Perdue; Shenghan Lai; Yiming Shao; J Brooks Jackson
HIV incidence, retention, and changes of high-risk behaviors among rural injection drug users in Guangxi, China.
Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 2006;27(4):53-61.
2006: Wei Liu; Jie Chen; Michelle Rodolph; Geetha Beauchamp; Benoît Mâsse; Shaoping Wang; Rongjian Li; Yuhua Ruan; Feng Zhou; Man-kit Leung; Shenghan Lai; Yiming Shao; J Brooks Jackson
HIV prevalence among injection drug users in rural Guangxi China.
Addiction (Abingdon, England) 2006;101(10):1493-8.
2006: Jessica D Church; Dana Jones; Tamara Flys; Donald Hoover; Natalia Marlowe; Shu Chen; Chanjuan Shi; James R Eshleman; Laura A Guay; J Brooks Jackson; Newton Kumwenda; Taha E Taha; Susan H Eshleman
Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D.
The Journal of molecular diagnostics : JMD 2006;8(4):430-2; quiz 527.
2006: Tamara Flys; Shu Chen; Dana C Jones; Donald R Hoover; Jessica D Church; Susan A Fiscus; Anthony Mwatha; Laura A Guay; Francis Mmiro; Philippa Musoke; Newton Kumwenda; Taha E Taha; J Brooks Jackson; Susan H Eshleman
Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D.
Journal of acquired immune deficiency syndromes (1999) 2006;42(5):610-3.
2006: Susan H Eshleman; Jessica D Church; Shu Chen; Laura A Guay; Anthony Mwatha; Susan A Fiscus; Francis Mmiro; Philippa Musoke; Newton Kumwenda; J Brooks Jackson; Taha E Taha; Donald R Hoover
Comparison of HIV-1 mother-to-child transmission after single-dose nevirapine prophylaxis among African women with subtypes A, C, and D.
Journal of acquired immune deficiency syndromes (1999) 2006;42(4):518-21.
2006: Susan H Eshleman; Dana Jones; Justin Galovich; Ellen Paxinos; Christos J Petropoulos; J Brooks Jackson; Neil Parkin
Phenotypic drug resistance patterns in subtype A HIV-1 clones with nonnucleoside reverse transcriptase resistance mutations.
AIDS research and human retroviruses 2006;22(3):289-93.
2006: Susan H Eshleman; Donald R Hoover; Sarah E Hudelson; Shu Chen; Susan A Fiscus; Estelle Piwowar-Manning; J Brooks Jackson; Newton Kumwenda; Taha E Taha
Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1.
The Journal of infectious diseases 2006;193(4):479-81.
2006: J Brooks Jackson; Teresa Parsons; Philippa Musoke; Clemensia Nakabiito; Deborah Donnell; Thomas Fleming; Mark Mirochnick; Lynne Mofenson; Mary Glenn Fowler; Francis Mmiro; Laura A Guay
Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission.
AIDS (London, England) 2006;20(2):217-22.
2005: Susan H Eshleman; Donald R Hoover; Shu Chen; Sarah E Hudelson; Laura A Guay; Anthony Mwatha; Susan A Fiscus; Francis Mmiro; Philippa Musoke; J Brooks Jackson; Newton Kumwenda; Taha E Taha
Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns.
AIDS (London, England) 2005;19(18):2167-9.
2005: Richard E Nettles; Tara L Keiffer; Joseph Cofrancesco; Joel E Gallant; Thomas C Quinn; J Brooks Jackson; Charles Flexner; Kathryn Carson; Albert W Wu; Robert Siliciano
Psychological distress and physical pain appear to have no short-term adverse impact on plasma HIV-1 RNA levels in patients on successful HAART.
HIV clinical trials 2005;6(5):262-71.
2005: Susan H Eshleman; Laura A Guay; Jing Wang; Anthony Mwatha; Elizabeth R Brown; Philippa Musoke; Francis Mmiro; J Brooks Jackson
Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012.
Journal of acquired immune deficiency syndromes (1999) 2005;40(1):24-9.
2005: Susan H Eshleman; Laura A Guay; Anthony Mwatha; Elizabeth Brown; Philippa Musoke; Francis Mmiro; J Brooks Jackson
Comparison of mother-to-child transmission rates in Ugandan women with subtype A versus D HIV-1 who received single-dose nevirapine prophylaxis: HIV Network For Prevention Trials 012.
Journal of acquired immune deficiency syndromes (1999) 2005;39(5):593-7.
2005: Susan H Eshleman; Donald R Hoover; Shu Chen; Sarah E Hudelson; Laura A Guay; Anthony Mwatha; Susan A Fiscus; Francis Mmiro; Philippa Musoke; J Brooks Jackson; Newton Kumwenda; Taha E Taha
Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.
The Journal of infectious diseases 2005;192(1):30-6.
2005: Tamara Flys; Dwight V Nissley; Cassidy W Claasen; Dana Jones; Chanjuan Shi; Laura A Guay; Philippa Musoke; Francis Mmiro; Jeffrey N Strathern; J Brooks Jackson; James R Eshleman; Susan H Eshleman
Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012.
The Journal of infectious diseases 2005;192(1):24-9.
2005: J Brooks Jackson; Thomas Fleming
A drug is effective if better than a harmless control.
Nature 2005;434(7037):1067.
2005: Dana Jones; Neil Parkin; Sarah E Hudelson; Laura A Guay; Philippa Musoke; Francis Mmiro; J Brooks Jackson; Susan H Eshleman
Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.
AIDS research and human retroviruses 2005;21(4):319-24.
2005: Tim R Cressey; Gonzague Jourdain; Marc Lallemant; Suparat Kunkeaw; J Brooks Jackson; Philippa Musoke; Edmund V Capparelli; Mark Mirochnick
Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1.
Journal of acquired immune deficiency syndromes (1999) 2005;38(3):283-8.
2005: Richard E Nettles; Tara L Kieffer; Patty Kwon; Daphne Monie; Yefei Han; Teresa Parsons; Joseph Cofrancesco; Joel E Gallant; Thomas C Quinn; J Brooks Jackson; Charles Flexner; Kathryn Carson; Stuart C Ray; Deborah Persaud; Robert Siliciano
Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART.
JAMA : the journal of the American Medical Association 2005;293(7):817-29.
2005: Richard D Semba; Christopher M Ndugwa; Robert T Perry; Tamara D Clark; J Brooks Jackson; George Melikian; James Tielsch; Francis Mmiro
Effect of periodic vitamin A supplementation on mortality and morbidity of human immunodeficiency virus-infected children in Uganda: A controlled clinical trial.
Nutrition (Burbank, Los Angeles County, Calif.) 2005;21(1):25-31.
2004: Natalia Marlowe; Tamara Flys; John Hackett; Michael Schumaker; J Brooks Jackson; Susan H Eshleman
Analysis of insertions and deletions in the gag p6 region of diverse HIV type 1 strains.
AIDS research and human retroviruses 2004;20(10):1119-25.
2004: Craig W Hendrix; Ann C Collier; Michael M Lederman; Dominique Schols; Richard B Pollard; Stephen Brown; J Brooks Jackson; Robert W Coombs; Marshall J Glesby; Charles Flexner; Gary J Bridger; Karin Badel; Ronald T MacFarland; Geoffrey Henson; Gary Calandra
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection.
Journal of acquired immune deficiency syndromes (1999) 2004;37(2):1253-62.
2004: Anna Coutsoudis; François Dabis; Wafaie Fawzi; Philippe Gaillard; Geert Haverkamp; D Robert Harris; J Brooks Jackson; Valerie Leroy; Nicolas Meda; Philippe Msellati; Marie-Louise Newell; Ruth Nsuati; Jennifer S Read; Stefan Wiktor
Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis.
The Journal of infectious diseases 2004;189(12):2154-66.
2004: Susan H Eshleman; Laura A Guay; Anthony Mwatha; Shawn P Cunningham; Elizabeth R Brown; Philippa Musoke; Francis Mmiro; J Brooks Jackson
Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012.
AIDS research and human retroviruses 2004;20(6):595-9.
2004: J Brooks Jackson; Estelle Piwowar-Manning; LeTanya Johnson-Lewis; Roland Bassett; Lisa M Demeter; Donald Brambilla
Comparison of versions 1.0 AND 1.5 of the UltraSensitive AMPLICOR HIV-1 MONITOR test for subjects with low viral load.
Journal of clinical microbiology 2004;42(6):2774-6.
2004: Susan H Eshleman; Laura A Guay; Anthony Mwatha; Elizabeth R Brown; Shawn P Cunningham; Philippa Musoke; Francis Mmiro; J Brooks Jackson
Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012).
Journal of acquired immune deficiency syndromes (1999) 2004;35(2):126-30.
2004: J Brooks Jackson; Francis Mmiro
HIVNET 012 and Petra.
Lancet 2004;363(9404):245; author reply 245-6.
2003: Jeffrey M Jacobson; Michael M Lederman; John Spritzler; Hernan Valdez; Pablo Tebas; Gail Skowron; Rui Wang; J Brooks Jackson; Lawrence Fox; Alan Landay; Mark J Gilbert; Dorothy O'Neil; Lynne Bancroft; Lena Al-Harthi; Mark A Jacobson; Thomas C Merigan; Marshall J Glesby
Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection.
The Journal of infectious diseases 2003;188(12):1804-14.
2003: J Brooks Jackson; Philippa Musoke; Thomas Fleming; Laura A Guay; Danstan Bagenda; Melissa Allen; Clemensia Nakabiito; Joseph Sherman; Paul M Bakaki; Maxensia Owor; Constance Ducar; Martina Deseyve; Anthony Mwatha; Lynda Emel; Corey Duefield; Mark Mirochnick; Mary Glenn Fowler; Lynne Mofenson; Paolo Miotti; Maria Gigliotti; Dorothy Bray; Francis Mmiro
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.
Lancet 2003;362(9387):859-68.
2003: Susan H Eshleman; Dana Jones; Tamara Flys; Olga Petrauskene; J Brooks Jackson
Analysis of HIV-1 variants by cloning DNA generated with the ViroSeq HIV-1 Genotyping System.
BioTechniques 2003;35(3):614-8, 620, 622.
2003: Estelle M Piwowar-Manning; Terry A Henderson; Lorraine Brisbin; J Brooks Jackson
A modified ultrasensitive assay to detect quantified HIV-1 RNA of fewer than 50 copies per milliliter.
American journal of clinical pathology 2003;120(2):268-70.
2003: Donald J Brambilla; Cheryl Jennings; Grace M Aldrovandi; James Bremer; Anne Marie Comeau; Sharon Cassol; Ruth Dickover; J Brooks Jackson; Jane Pitt; John L Sullivan; Ann Butcher; Lynell Grosso; Patricia Reichelderfer; Susan A Fiscus
Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability.
Journal of clinical microbiology 2003;41(5):1888-93.
2003: J Brooks Jackson; Scott Barnett; Estelle Piwowar-Manning; LINDA APUZZO; Charles Raines; Craig W Hendrix; Fayez M Hamzeh; Joel E Gallant
A phase I/II study of nevirapine for pre-exposure prophylaxis of HIV-1 transmission in uninfected subjects at high risk.
AIDS (London, England) 2003;17(4):547-53.
2002: Susan H Eshleman; Laura A Guay; Thomas Fleming; Anthony Mwatha; Martin R Mracna; Graziella Becker-Pergola; Philippa Musoke; Francis Mmiro; J Brooks Jackson
Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012).
Journal of acquired immune deficiency syndromes (1999) 2002;31(3):327-30.
2002: Sheila M Keating; Robert Bollinger; Thomas C Quinn; J Brooks Jackson; Lucy Minnich Carruth
Cross-clade T lymphocyte-mediated immunity to HIV type 1: implications for vaccine design and immunodetection assays.
AIDS research and human retroviruses 2002;18(14):1067-79.
2002: Newton Kumwenda; Paolo Miotti; Taha E Taha; Robin L Broadhead; Robert J Biggar; J Brooks Jackson; George Melikian; Richard D Semba
Antenatal vitamin A supplementation increases birth weight and decreases anemia among infants born to human immunodeficiency virus-infected women in Malawi.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(5):618-24.
2002: Alexandra M Klevytska; Martin R Mracna; Laura A Guay; Graziella Becker-Pergola; Manohar Furtado; Linqi Zhang; J Brooks Jackson; Susan H Eshleman
Analysis of length variation in the V1-V2 region of env in nonsubtype B HIV type 1 from Uganda.
AIDS research and human retroviruses 2002;18(11):791-6.
2002: Laura A Guay; Philippa Musoke; David L Hom; Clemensia Nakabiito; Danstan Bagenda; Courtney V Fletcher; Lawrence H Marum; Mary Glenn Fowler; Lars G Falksveden; Britta Wahren; Peter Kataaha; Hans Wigzell; Francis Mmiro; J Brooks Jackson
Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in Uganda.
AIDS (London, England) 2002;16(10):1391-400.
2002: Janet Vargo; Katie Smith; Caroline Knott; Songbai Wang; Chyang Fang; Sherrol H McDonough; Cristina Giachetti; Sally Caglioti; Richard Gammon; Denise Gilbert; J Brooks Jackson; William Richards; Susan L Stramer; Larry T Mimms
Clinical specificity and sensitivity of a blood screening assay for detection of HIV-1 and HCV RNA.
Transfusion 2002;42(7):876-85.
2002: J Brooks Jackson; K Smith; C Knott; A Korpela; A Simmons; E Piwowar-Manning; Sherrol H McDonough; Larry T Mimms; J M Vargo
Sensitivity of the Procleix HIV-1/HCV assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA in a high-risk population.
Journal of clinical microbiology 2002;40(7):2387-91.
2002: Lisa M Demeter; Ronald J Bosch; Robert W Coombs; Susan A Fiscus; James Bremer; Victoria A Johnson; Alejo Erice; J Brooks Jackson; Stephen A Spector; Kathleen M Squires; Margaret A Fischl; Michael D Hughes; Scott M Hammer
Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500 or 50 copies per milliliter.
Journal of clinical microbiology 2002;40(6):2089-94.
2002: Susan H Eshleman; Matthew J Gonzales; Graziella Becker-Pergola; Shawn C Cunningham; Laura A Guay; J Brooks Jackson; Robert W Shafer
Identification of Ugandan HIV type 1 variants with unique patterns of recombination in pol involving subtypes A and D.
AIDS research and human retroviruses 2002;18(7):507-11.
2002: Paul Krogstad; Susan H Eshleman; Yongzhi Geng; J Brooks Jackson; Michael Wantman; Bette Korber; Dorothy Lang; Andrew Wiznia; George M Johnson; Sharon Nachman; Paul Palumbo
Mother-to-child transmission in the United States of subtypes D and A/G human immunodeficiency virus type 1.
AIDS research and human retroviruses 2002;18(6):413-7.
2002: Susan H Eshleman; J Brooks Jackson
Nevirapine resistance after single dose prophylaxis.
AIDS reviews 2002;4(2):59-63.
2002: Paul Krogstad; Sophia Lee; George Johnson; Kenneth Stanley; James McNamara; Jack Moye; J Brooks Jackson; Rosaura Aguayo; Arry Dieudonne; Margaret Khoury; Hermann Mendez; Sharon Nachman; Andrew Wiznia
Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(7):991-1001.
2002: Tamara D Clark; Francis Mmiro; Christopher M Ndugwa; Robert T Perry; J Brooks Jackson; George Melikian; Richard D Semba
Risk factors and cumulative incidence of anaemia among human immunodeficiency virus-infected children in Uganda.
Annals of tropical paediatrics 2002;22(1):11-7.
2002: Dana Totin; Christopher M Ndugwa; Francis Mmiro; Robert T Perry; J Brooks Jackson; Richard D Semba
Iron deficiency anemia is highly prevalent among human immunodeficiency virus-infected and uninfected infants in Uganda.
The Journal of nutrition 2002;132(3):423-9.
2001: Lisa M Demeter; Michael D Hughes; Robert W Coombs; J Brooks Jackson; J M Grimes; Ronald J Bosch; Susan A Fiscus; Stephen A Spector; Kathleen E Squires; Margaret A Fischl; Scott M Hammer
Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320.
Annals of internal medicine 2001;135(11):954-64.
2001: Martin R Mracna; Graziella Becker-Pergola; J Dileanis; Laura A Guay; S Cunningham; J Brooks Jackson; Susan H Eshleman
Performance of Applied Biosystems ViroSeq HIV-1 Genotyping System for sequence-based analysis of non-subtype B human immunodeficiency virus type 1 from Uganda.
Journal of clinical microbiology 2001;39(12):4323-7.
2001: Susan H Eshleman; Martin R Mracna; Laura A Guay; Martina Deseyve; S Cunningham; Mark Mirochnick; Philippa Musoke; Thomas Fleming; M Glenn Fowler; Lynne M Mofenson; Francis Mmiro; J Brooks Jackson
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).
AIDS (London, England) 2001;15(15):1951-7.
2001: Susan H Eshleman; Graziella Becker-Pergola; Martina Deseyve; Laura A Guay; Martin R Mracna; Thomas Fleming; S Cunningham; Philippa Musoke; Francis Mmiro; J Brooks Jackson
Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study).
The Journal of infectious diseases 2001;184(7):914-7.
2001: George Melikian; Francis Mmiro; Christopher M Ndugwa; R Perry; J Brooks Jackson; Elizabeth Garrett-Mayer; James Tielsch; Richard D Semba
Relation of vitamin A and carotenoid status to growth failure and mortality among Ugandan infants with human immunodeficiency virus.
Nutrition (Burbank, Los Angeles County, Calif.) 2001;17(7-8):567-72.
2001: Susan H Eshleman; Paul Krogstad; J Brooks Jackson; Y G Wang; S Lee; L J Wei; S Cunningham; Michael Wantman; Andrew Wiznia; G Johnson; Sharon Nachman; Paul Palumbo
Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377).
The Journal of infectious diseases 2001;183(12):1732-8.
2001: S Cunningham; B Ank; D Lewis; W Lu; Michael Wantman; J A Dileanis; J Brooks Jackson; Paul Palumbo; Paul Krogstad; Susan H Eshleman
Performance of the applied biosystems ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for sequence-based analysis of HIV-1 in pediatric plasma samples.
Journal of clinical microbiology 2001;39(4):1254-7.
2001: Jeffrey M Jacobson; John Greenspan; John Spritzler; Lawrence Fox; John L Fahey; J Brooks Jackson; Miriam Chernoff; David A Wohl; J J Pulvirenti; Thomas Hooton; Cecilia M Shikuma
Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers.
The Journal of infectious diseases 2001;183(2):343-346.
2000: Charles Raines; Charles Flexner; Eugene Sun; ME Heath-Chiozzi; R H Lewis; C Fields; Carl O Deetz; LINDA APUZZO; Susan H Eshleman; J Brooks Jackson; Joel E Gallant
Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeks.
Journal of acquired immune deficiency syndromes (1999) 2000;25(4):322-8.
2000: Laura A Guay; David L Hom; S R Kabengera; Estelle Piwowar-Manning; Peter Kataaha; Christopher M Ndugwa; Lawrence H Marum; Israel Kalyesubula; J Brooks Jackson
HIV-1 ICD p24 antigen detection in ugandan infants: use in early diagnosis of infection and as a marker of disease progression.
Journal of medical virology 2000;62(4):426-34.
2000: Elliot Marseille; James G Kahn; Francis Mmiro; Laura A Guay; Philippa Musoke; Mary Glenn Fowler; J Brooks Jackson
The cost effectiveness of a single-dose nevirapine regimen to mother and infant to reduce vertical HIV-1 transmission in sub-Saharan Africa.
Annals of the New York Academy of Sciences 2000;918():53-6.
2000: Andrew Wiznia; Kenneth Stanley; Paul Krogstad; George Johnson; Sophia Lee; James McNamara; Jack Moye; J Brooks Jackson; Hermann Mendez; R Aguayo; Arry Dieudonne; A Kovacs; M Bamji; Elaine J Abrams; S Rana; J Sever; Sharon Nachman
Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clinical Trials Group 377 Study Team.
AIDS research and human retroviruses 2000;16(12):1113-21.
2000: Graziella Becker-Pergola; JL Mellquist; Laura A Guay; Francis Mmiro; Christopher M Ndugwa; Peter Kataaha; J Brooks Jackson; Susan H Eshleman
Identification of diverse HIV type 1 subtypes and dual HIV type 1 infection in pregnant Ugandan women.
AIDS research and human retroviruses 2000;16(12):1099-104.
2000: Alejo Erice; Donald J Brambilla; J Bremer; J Brooks Jackson; R Kokka; Belinda Yen-Lieberman; Robert W Coombs
Performance characteristics of the QUANTIPLEX HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma.
Journal of clinical microbiology 2000;38(8):2837-45.
2000: J Brooks Jackson; Graziella Becker-Pergola; Laura A Guay; Philippa Musoke; Martin R Mracna; Mary Glenn Fowler; Lynne M Mofenson; Mark Mirochnick; Francis Mmiro; Susan H Eshleman
Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.
AIDS (London, England) 2000;14(11):F111-5.
2000: Graziella Becker-Pergola; Peter Kataaha; L Johnston-Dow; GEORGE FUNG; J Brooks Jackson; Susan H Eshleman
Analysis of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adults.
AIDS research and human retroviruses 2000;16(8):807-13.
2000: S Kim; Michael D Hughes; Scott M Hammer; J Brooks Jackson; Victor DeGruttola; David A Katzenstein
Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.
AIDS research and human retroviruses 2000;16(7):645-53.
2000: M P Busch; S H Kleinman; J Brooks Jackson; Susan L Stramer; Indira K Hewlett; S Preston
Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors.
Transfusion 2000;40(2):143-59.
1999: Graziella Becker-Pergola; JL Mellquist; James R Eshleman; J Brooks Jackson; Susan H Eshleman
Improved detection of human immunodeficiency virus type 1 variants by analysis of replicate amplification reactions: relevance to studies of human immunodeficiency virus type 1 vertical transmission.
Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology 1999;4(4):261-8.
1999: Donald J Brambilla; Patricia Reichelderfer; James Bremer; David E Shapiro; Ronald C Hershow; D A Katzenstein; S M Hammer; J Brooks Jackson; A C Collier; Rhoda S Sperling; Mary Glenn Fowler; Robert W Coombs
The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance Program.
AIDS (London, England) 1999;13(16):2269-79.
1999: Elliot Marseille; James G Kahn; Francis Mmiro; Laura A Guay; Philippa Musoke; Mary Glenn Fowler; J Brooks Jackson
Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
Lancet 1999;354(9181):803-9.
1999: Laura A Guay; Philippa Musoke; Thomas Fleming; Danstan Bagenda; Melissa Allen; Clemensia Nakabiito; J Sherman; Paul M Bakaki; Constance Ducar; Martina Deseyve; Lynda Emel; Mark Mirochnick; Mary Glenn Fowler; Lynne Mofenson; Paolo Miotti; K Dransfield; D Bray; Francis Mmiro; J Brooks Jackson
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.
Lancet 1999;354(9181):795-802.
1999: P M Garcia; Leslie A Kalish; Jane Pitt; Howard Minkoff; Thomas C Quinn; S K Burchett; J Kornegay; J Brooks Jackson; Jack Moye; C Hanson; Carmen D Zorrilla; J F Lew
Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.
The New England journal of medicine 1999;341(6):394-402.
1999: Jeffrey M Jacobson; John Spritzler; Lawrence Fox; John L Fahey; J Brooks Jackson; Miriam Chernoff; David A Wohl; Albert W Wu; Thomas Hooton; Beverly E Sha; Cecilia M Shikuma; Laurie MacPhail; David M Simpson; Carol B Trapnell; N Basgoz
Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group.
The Journal of infectious diseases 1999;180(1):61-7.
1999: J Brooks Jackson
Progress in reducing mother-to-infant HIV transmission.
The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service 1999;11(3):2, 11.
1999: Douglas A Jabs; M Forman; Cheryl Enger; J Brooks Jackson
Comparison of cytomegalovirus loads in plasma and leukocytes of patients with cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group.
Journal of clinical microbiology 1999;37(5):1431-5.
1999: Philippa Musoke; Laura A Guay; Danstan Bagenda; Mark Mirochnick; Clemensia Nakabiito; Thomas Fleming; T Elliott; S Horton; K Dransfield; J W Pav; A Murarka; Melissa Allen; Mary Glenn Fowler; Lynne Mofenson; David L Hom; Francis Mmiro; J Brooks Jackson
A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).
AIDS (London, England) 1999;13(4):479-86.
1999: JL Mellquist; Graziella Becker-Pergola; J Gu; Laura A Guay; L Himes; Peter Kataaha; Francis Mmiro; Christopher M Ndugwa; J Brooks Jackson; Susan H Eshleman
Dual transmission of subtype A and D HIV type 1 viruses from a Ugandan woman to her infant.
AIDS research and human retroviruses 1999;15(2):217-21.
1998: JL Mellquist; B Bowman; Lakshmi Kasturi; Laura A Guay; Peter Kataaha; Francis Mmiro; Christopher M Ndugwa; J Brooks Jackson; Susan H Eshleman
Characterization of HIV type 1 gp120 V3 region sequences from Ugandan infants.
AIDS research and human retroviruses 1998;14(15):1391-5.
1998: J McCullough; C Bianco; M Busch; R Dodd; I K Hewlett; J Brooks Jackson; L M Katz; J McFarland; P A Mied; P Page; M. Sue Preston; T Simon; Susan L Stramer; D Stroncek; C T Young
Interagency Genome Amplification Testing Task Force: preliminary report.
Transfusion 1998;38(10):903-4.
1998: J Lew; Patricia Reichelderfer; Mary Glenn Fowler; James Bremer; R Carrol; Sharon Cassol; David Chernoff; R Coombs; Mike Cronin; Ruth Dickover; Susan A Fiscus; S Herman; J Brooks Jackson; J Kornegay; Andrea Kovacs; K McIntosh; W Meyer; N Michael; Lynne Mofenson; Jack Moye; Thomas C Quinn; M Robb; Maryanne Vahey; Barbara Weiser; T Yeghiazarian
Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics.
Journal of clinical microbiology 1998;36(6):1471-9.
1998: Lisa A Cavacini; Matthew H Samore; J Gambertoglio; J Brooks Jackson; Mark Duval; AV Wisnewski; S Hammer; C Koziel; C Trapnell; Marshall R Posner
Phase I study of a human monoclonal antibody directed against the CD4-binding site of HIV type 1 glycoprotein 120.
AIDS research and human retroviruses 1998;14(7):545-50.
1998: Susan A Fiscus; Michael D Hughes; Janet L Lathey; T Pi; J Brooks Jackson; Suraiya Rasheed; T Elbeik; R Reichman; AJ Japour; R Byington; Walter A Scott; B P Griffith; David A Katzenstein; Scott M Hammer
Changes in virologic markers as predictors of CD4 cell decline and progression of disease in human immunodeficiency virus type 1-infected adults treated with nucleosides. AIDS Clinical Trials Group Protocol 175 Team.
The Journal of infectious diseases 1998;177(3):625-33.
1998: Janet L Lathey; Michael D Hughes; Susan A Fiscus; T Pi; J Brooks Jackson; Suraiya Rasheed; T Elbeik; R Reichman; AJ Japour; Richard T D'Aquila; Walter A Scott; B P Griffith; Scott M Hammer; David A Katzenstein
Variability and prognostic values of virologic and CD4 cell measures in human immunodeficiency virus type 1-infected patients with 200-500 CD4 cells/mm(3) (ACTG 175). AIDS Clinical Trials Group Protocol 175 Team.
The Journal of infectious diseases 1998;177(3):617-24.
1997: Catherine A Brennan; JK Lund; Alan Golden; Julie Yamaguchi; Ana Vallari; J F Phillips; P K Kataaha; J Brooks Jackson; Sushil G Devare
Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda.
AIDS (London, England) 1997;11(15):1823-32.
1997: A E Brown; J Brooks Jackson; S A Fuller; J Sheffield; M A Cannon; J R Lane
Viral RNA in the resolution of human immunodeficiency virus type 1 diagnostic serology.
Transfusion 1997;37(9):926-9.
1997: Jeffrey M Jacobson; John Greenspan; John Spritzler; N Ketter; John L Fahey; J Brooks Jackson; Lawrence Fox; Miriam Chernoff; Albert W Wu; Laurie MacPhail; G J Vasquez; David A Wohl
Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.
The New England journal of medicine 1997;336(21):1487-93.
1997: J Brooks Jackson; J S Parsons; L S Nichols; N Knoble; S Kennedy; E M Piwowar
Detection of human immunodeficiency virus type 1 (HIV-1) antibody by western blotting and HIV-1 DNA by PCR in patients with AIDS.
Journal of clinical microbiology 1997;35(5):1118-21.
1997: J Brooks Jackson; E M Piwowar; J Parsons; Peter Kataaha; G Bihibwa; J Onecan; S Kabengera; S D Kennedy; A Butcher
Detection of human immunodeficiency virus type 1 (HIV-1) DNA and RNA sequences in HIV-1 antibody-positive blood donors in Uganda by the Roche AMPLICOR assay.
Journal of clinical microbiology 1997;35(4):873-6.
1997: J Brooks Jackson
Human immunodeficiency virus-indeterminate western blot and abortive infection.
Transfusion 1997;37(1):1-2.
1996: Robert M Grant; E M Piwowar; E Katongole-Mbidde; W Muzawalu; S Rugera; J Abima; S L Stramer; Peter Kataaha; J Brooks Jackson
Comparison of saliva and serum for human immunodeficiency virus type 1 antibody testing in Uganda using a rapid recombinant assay.
Clinical and diagnostic laboratory immunology 1996;3(6):640-4.
1996: Belinda Yen-Lieberman; Donald J Brambilla; J Brooks Jackson; James Bremer; R Coombs; Mike Cronin; S Herman; D Katzenstein; S Leung; HJ Lin; P Palumbo; Suraiya Rasheed; J Todd; Maryanne Vahey; Patricia Reichelderfer
Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories.
Journal of clinical microbiology 1996;34(11):2695-701.
1996: David A Katzenstein; Scott M Hammer; Michael D Hughes; H Gundacker; J Brooks Jackson; Susan A Fiscus; Suraiya Rasheed; T Elbeik; Richard C Reichman; AJ Japour; T C Merigan; Martin S Hirsch
The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.
The New England journal of medicine 1996;335(15):1091-8.
1996: Robert Wallis; Peter Nsubuga; Christopher Curtis Whalen; Roy D Mugerwa; Alphonse Okwera; D Oette; J Brooks Jackson; John L Johnson; Jerrold Jay Ellner
Pentoxifylline therapy in human immunodeficiency virus-seropositive persons with tuberculosis: a randomized, controlled trial.
The Journal of infectious diseases 1996;174(4):727-33.
1996: Robert W Coombs; Seth Welles; C Hooper; Patricia Reichelderfer; Richard T D'Aquila; AJ Japour; Victoria A Johnson; Daniel R Kuritzkes; Douglas D Richman; S Kwok; J Todd; J Brooks Jackson; Victor DeGruttola; Clyde S Crumpacker; J Kahn
Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working Groups.
The Journal of infectious diseases 1996;174(4):704-12.
1996: Seth Welles; J Brooks Jackson; Belinda Yen-Lieberman; Lisa M Demeter; AJ Japour; Laura M Smeaton; Victoria A Johnson; Daniel R Kuritzkes; Richard T D'Aquila; P A Reichelderfer; Douglas D Richman; Richard C Reichman; Margaret A Fischl; R Dolin; Robert W Coombs; J O Kahn; C McLaren; J Todd; S Kwok; Clyde S Crumpacker
Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 Team.
The Journal of infectious diseases 1996;174(4):696-703.
1996: Laura A Guay; David L Hom; Francis Mmiro; E M Piwowar; S Kabengera; J Parsons; Christopher M Ndugwa; Lawrence H Marum; Karen Olness; Peter Kataaha; J Brooks Jackson
Detection of human immunodeficiency virus type 1 (HIV-1) DNA and p24 antigen in breast milk of HIV-1-infected Ugandan women and vertical transmission.
Pediatrics 1996;98(3 Pt 1):438-44.
1996: J Brooks Jackson; David L Hom; E Piwowar; Christopher M Ndugwa; Peter Kataaha; Lawrence H Marum; Laura A Guay; J Parsons; Karen Olness; Francis Mmiro
Maternal HIV-1 RNA serum levels at delivery and vertical transmission in Uganda.
Pediatric AIDS and HIV infection 1996;7(1):37-42.
1995: J Brooks Jackson
Acute decrease in HIV-1 viral load after initiation of zidovudine therapy: implications for interrupting vertical transmission.
Pediatric AIDS and HIV infection 1995;6(6):358-9.
1995: Michael M Lederman; J Brooks Jackson; B L Kroner; G C White; M E Eyster; L M Aledort; M W Hilgartner; C M Kessler; A R Cohen; K P Kiger
Human immunodeficiency virus (HIV) type 1 infection status and in vitro susceptibility to HIV infection among high-risk HIV-1-seronegative hemophiliacs.
The Journal of infectious diseases 1995;172(1):228-31.
1995: Mark Holodniy; L Mole; Belinda Yen-Lieberman; D Margolis; C Starkey; R Carroll; T Spahlinger; J Todd; J Brooks Jackson
Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT, and standard VACUTAINER tubes.
Journal of clinical microbiology 1995;33(6):1562-6.
1995: E R Stiehm; L Mofenson; Susan Zolla-Pazner; J Brooks Jackson; N L Martin; A J Ammann
Summary of the workshop on passive immunotherapy in the prevention and treatment of HIV infection. The Passive Antibody Workshop Participants.
Clinical immunology and immunopathology 1995;75(1):84-93.
1995: J Brooks Jackson; M R Hanson; G M Johnson; T G Spahlinger; H F Polesky; R J Bowman
Long-term follow-up of blood donors with indeterminate human immunodeficiency virus type 1 results on Western blot.
Transfusion 1995;35(2):98-102.
1994: Patricia Reichelderfer; J Brooks Jackson
Quality assurance and use of PCR in clinical trials.
PCR methods and applications 1994;4(3):S141-9.
1994: Philip Toltzis; C M Marx; H H Balfour; J Brooks Jackson
Use of semiquantitative human immunodeficiency virus type 1 culture to guide therapy in a premature infant.
American journal of clinical pathology 1994;101(6):753-5.
1994: R C Kalayjian; G Skowron; R T Emgushov; M Chance; S A Spell; P R Borum; L S Webb; K H Mayer; J Brooks Jackson; B Yen-Lieberman
A phase I/II trial of intravenous L-2-oxothiazolidine-4-carboxylic acid (procysteine) in asymptomatic HIV-infected subjects.
Journal of acquired immune deficiency syndromes 1994;7(4):369-74.
1994: J G McNamara; M Rogers; K Goldenthal; J Brooks Jackson; P Rossi; T Fenton; Patricia Fast
Conference on advances in AIDS vaccine development--1993. Report of Perinatal Intervention Working Group.
AIDS research and human retroviruses 1994;10 Suppl 2():S161-4.
1993: J Brooks Jackson; J Drew; H J Lin; P Otto; J W Bremer; F Blaine Hollinger; Steven Wolinsky
Establishment of a quality assurance program for human immunodeficiency virus type 1 DNA polymerase chain reaction assays by the AIDS Clinical Trials Group. ACTG PCR Working Group, and the ACTG PCR Virology Laboratories.
Journal of clinical microbiology 1993;31(12):3123-8.
1993: Alan Landay; J L Ho; David L Hom; T Russell; R Zwerner; J G Minuty; Peter Kataaha; Francis Mmiro; J Brooks Jackson
A rapid manual method for CD4+ T-cell quantitation for use in developing countries.
AIDS (London, England) 1993;7(12):1565-8.
1993: J Brooks Jackson; Peter Kataaha; David L Hom; Francis Mmiro; Laura A Guay; Christopher M Ndugwa; Lawrence H Marum; E Piwowar; K Brewer; G Toedter
Beta 2-microglobulin, HIV-1 p24 antibody and acid-dissociated HIV-1 p24 antigen levels: predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women.
AIDS (London, England) 1993;7(11):1475-9.
1993: S Hammer; C Crumpacker; Richard T D'Aquila; J Brooks Jackson; J Lathey; D Livnat; Patricia Reichelderfer
Use of virologic assays for detection of human immunodeficiency virus in clinical trials: recommendations of the AIDS Clinical Trials Group Virology Committee.
Journal of clinical microbiology 1993;31(10):2557-64.
1993: J Brooks Jackson
Detection and quantitation of human immunodeficiency virus type 1 using molecular DNA/RNA technology.
Archives of pathology & laboratory medicine 1993;117(5):473-7.
1992: D R Henrard; J Phillips; S Burchett; J Brooks Jackson; Peter Kataaha; Francis Mmiro; Christopher M Ndugwa
Plasma viral load in symptom-free women and vertical transmission of HIV-1.
Lancet 1992;340(8833):1470-1.
1992: J Brooks Jackson
Human immunodeficiency virus (HIV)-indeterminate western blots and latent HIV infection.
Transfusion 1992;32(6):497-9.
1991: J Brooks Jackson; Christopher M Ndugwa; Francis Mmiro; Peter Kataaha; Laura A Guay; E A Dragon; J Goldfarb; Karen Olness
Non-isotopic polymerase chain reaction methods for the detection of HIV-1 in Ugandan mothers and infants.
AIDS (London, England) 1991;5(12):1463-7.
1991: P T Conover; C T Fang; E Lam; N V Hirschler; J Brooks Jackson; Roslyn Yomtovian
Antibodies to hepatitis C virus in autologous blood donors.
Transfusion 1991;31(7):616-9.
1991: J Brooks Jackson; Laura A Guay; J Goldfarb; Karen Olness; Christopher M Ndugwa; Francis Mmiro; Peter Kataaha; J P Allain
Hepatitis C virus antibody in HIV-1 infected Ugandan mothers.
Lancet 1991;337(8740):551.
1991: Phillip K Peterson; Burt Sharp; Genya Gekker; J Brooks Jackson; Henry H Balfour
Opiates, human peripheral blood mononuclear cells, and HIV.
Advances in experimental medicine and biology 1991;288():171-8.
1990: K Henry; S Campbell; J Brooks Jackson; Henry H Balfour; F Rhame; K Sannerud; S Pollack; J Sninsky; S Kwok
Long-term follow-up of health care workers with work-site exposure to human immunodeficiency virus.
JAMA : the journal of the American Medical Association 1990;263(13):1765-6.
1990: J Brooks Jackson
Human immunodeficiency virus type 1 antigen and culture assays.
Archives of pathology & laboratory medicine 1990;114(3):249-53.
1990: J Brooks Jackson; K L MacDonald; J Cadwell; C Sullivan; W E Kline; M Hanson; K J Sannerud; S L Stramer; N J Fildes; S Y Kwok
Absence of HIV infection in blood donors with indeterminate western blot tests for antibody to HIV-1.
The New England journal of medicine 1990;322(4):217-22.
1990: J Brooks Jackson
The polymerase chain reaction in transfusion medicine.
Transfusion 1990;30(1):51-7.
1990: J Brooks Jackson; S Y Kwok; J J Sninsky; J S Hopsicker; K J Sannerud; F S Rhame; K Henry; M Simpson; Henry H Balfour
Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals.
Journal of clinical microbiology 1990;28(1):16-9.
1989: K Henry; D Dexter; K Sannerud; J Brooks Jackson; Henry H Balfour
Recovery of HIV at autopsy.
The New England journal of medicine 1989;321(26):1833-4.
1989: K L MacDonald; J Brooks Jackson; R J Bowman; H F Polesky; F S Rhame; H H Balfour; Michael Osterholm
Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications.
Annals of internal medicine 1989;110(8):617-21.
1989: J Brooks Jackson; S Y Kwok; J S Hopsicker; K J Sannerud; J J Sninsky; J R Edson; Henry H Balfour
Absence of HIV-1 infection in antibody-negative sexual partners of HIV-1 infected hemophiliacs.
Transfusion 1989;29(3):265-7.
1989: J Brooks Jackson; K J Sannerud; Henry H Balfour
Comparison of two serum HIV antigen assays for selection of asymptomatic antigenemic individuals into clinical trials.
Journal of acquired immune deficiency syndromes 1989;2(4):394-7.
1988: J Brooks Jackson; K J Sannerud; J S Hopsicker; S Y Kwok; J R Edson; Henry H Balfour
Hemophiliacs with HIV antibody are actively infected.
JAMA : the journal of the American Medical Association 1988;260(15):2236-9.
1988: J Brooks Jackson; R W Coombs; K Sannerud; F S Rhame; Henry H Balfour
Rapid and sensitive viral culture method for human immunodeficiency virus type 1.
Journal of clinical microbiology 1988;26(7):1416-8.
1988: J Brooks Jackson; K Sannerud; F S Rhame; Henry H Balfour
Evaluation of two commercial tests for human immunodeficiency virus antigens in culture supernatant fluid.
American journal of clinical pathology 1988;89(6):788-90.
1988: J Brooks Jackson; A Erice; J A Englund; J R Edson; Henry H Balfour
Prevalence of cytomegalovirus antibody in hemophiliacs and homosexuals infected with human immunodeficiency virus type 1.
Transfusion 1988;28(2):187-9.
1988: J Brooks Jackson; Henry H Balfour
Practical diagnostic testing for human immunodeficiency virus.
Clinical microbiology reviews 1988;1(1):124-38.
1987: J Brooks Jackson; H T Orr; J J McCullough; M Colin Jordan
Failure to detect human cytomegalovirus DNA in IgM-seropositive blood donors by spot hybridization.
The Journal of infectious diseases 1987;156(6):1013-6.
1987: J Brooks Jackson; K Sannerud; F Rhame; R Tsang; Henry H Balfour
Comparison of reverse transcriptase assay with the Retro-Tek viral capture assay for detection of human immunodeficiency virus.
Diagnostic microbiology and infectious disease 1987;7(3):185-92.